Login Register Cart 0
Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Design and Fabrication of Gallic Acid Loaded Chitosan Nanoformulation

Author(s): Kalyani Pathak*, Ratna Jyoti Das, Riya Saikia, Jon Jyoti Sahariah, Hemanta Pathak, Himangshu Sarma and Aparoop Das

Volume 12, Issue 2, 2022

Published on: 22 June, 2022

Page: [135 - 148] Pages: 14

DOI: 10.2174/2210303112666220512154520

Price: $65

Abstract

Background: Gallic acid is a natural phenolic compound found in several fruits and medicinal plants. It is reported to have several health-promoting effects, including antioxidant, antiinflammatory, antidiabetic, and antineoplastic properties in gastrointestinal, neuropsychological, metabolic, and cardiovascular disorders.

Aims: The aim of the present work was to study the influence of formulation factors on the physicochemical properties of gallic acid-loaded chitosan nanoparticles in order to optimize the formulation.

Methods: Active chitosan nanoparticles could be used to support the modification of gallic acid delivery. The nanoparticles were prepared by the emulsification-solvent evaporation method using sonication. A 3-factor, 2-level BBD (Box-Behnken Design) was applied for exploring and optimizing the main effects, quadratic effects, as well as interaction effects of the ingredients of the formulation on the performance of the nanoparticles. The responses like particle size, polydispersity index, zeta potential, and encapsulation efficiency were also determined.

Results: The concentration of gallic acid nanoparticles seems to be the most critical element affecting their properties. The concentration of chitosan was increased, which resulted in an increase in particle size. The optimised drug-loaded nanoparticles have a zeta potential of -5.2 mV due to their largely negative surface charge. Although the measured zeta potential was low, the nanoparticle dispersion remained stable, and no significant change in the shape or particle size of the gallic acidloaded chitosan nanoparticles was seen after two weeks at 4°C. The gallic acid-loaded nanoparticles have a particle size of 230 nm. Gallic acid reduced the particle size after it was added. One probable explanation for this is that the loaded medicine increased the cohesive force of the hydrophobic contact, resulting in the size reduction. A formulation was optimised based on the acquired results, and the experimental values were comparable to the expected values. FTIR examination revealed that gallic acid-loaded chitosan nanoparticles displayed both hydrogen bond and ionic interactions, allowing for active agent encapsulation and augmentation.

Conclusion: The overall results indicated that by decreasing the chitosan concentration, drug entrapment efficiency increased and gallic acid concentration was the main factor influencing particle size, while entrapment efficiency was predominantly affected by the chitosan concentration.

Keywords: Nanoparticle, gallic acids, experimental design, Box-Behnken, optimization, off-flavors.

« Previous Next »
[1]
Verma, S.; Singh, A.; Mishra, A. Gallic acid: Molecular rival of cancer. Environ. Toxicol. Pharmacol., 2013, 35(3), 473-485.
[http://dx.doi.org/10.1016/j.etap.2013.02.011] [PMID: 23501608]
[2]
Lamarra, J.; Rivero, S.; Pinotti, A. Design of chitosan-based nanoparticles functionalized with gallic acid. Mater. Sci. Eng. C, 2016, 67, 717-726.
[http://dx.doi.org/10.1016/j.msec.2016.05.072] [PMID: 27287172]
[3]
Schreiber, S.B.; Bozell, J.J.; Hayes, D.G.; Zivanovic, S. Introduction of primary antioxidantactivity to chitosan for application as a multi-functional food packaging material. Food Hydrocoll., 2013, 33(2), 207-214.
[http://dx.doi.org/10.1016/j.foodhyd.2013.03.006]
[4]
Xie, M.; Hu, B.; Wang, Y.; Zeng, X. Grafting of gallic acid onto chitosan enhances antioxidant activities and alters rheological properties of the copolymer. J. Agric. Food Chem., 2014, 62(37), 9128-9136.
[http://dx.doi.org/10.1021/jf503207s] [PMID: 25198516]
[5]
Nagpal, K.; Singh, S.K.; Mishra, D.N. Nanoparticle mediated brain targeted delivery of gallic acid: In vivo behavioral and biochemical stud-ies for improved antioxidant and antidepressant-like activity. Drug Deliv., 2012, 19(8), 378-391.
[http://dx.doi.org/10.3109/10717544.2012.738437] [PMID: 23173579]
[6]
Konecsni, K.; Low, N.H.; Nickerson, M.T. Chitosan-tripolyphos-phate submicron particles as the carrier of entrapped rutin. Food Chem., 2012, 134(4), 1775-1779.
[http://dx.doi.org/10.1016/j.foodchem.2012.03.070] [PMID: 23442620]
[7]
Atar, N.; Eren, T.; Yola, M.L. A molecular imprinted SPR biosensor for sensitive determination of citrinin in red yeast rice. Food Chem., 2015, 184, 7-11.
[http://dx.doi.org/10.1016/j.foodchem.2015.03.065] [PMID: 25872420]
[8]
Eren, T.; Atar, N.; Yola, M.L.; Karimi-Maleh, H. A sensitive molecularly imprinted polymer based quartz crystal microbalance nanosen-sor for selective determination of lovastatin in red yeast rice. Food Chem., 2015, 185, 430-436.
[http://dx.doi.org/10.1016/j.foodchem.2015.03.153] [PMID: 25952889]
[9]
Fiorda, F.A.; Soares, M.S., Jr; da Silva, F.A.; de Moura, C.M.; Grossmann, M.V. Physicalquality of snacks and technological properties of pre-gelatinized flours formulated with cassava starch and dehydrated cassava bagasse as a function ofextrusion variables. Lebensm. Wiss. Technol., 2015, 62(2), 1112-1119.
[http://dx.doi.org/10.1016/j.lwt.2015.02.030]
[10]
Calvo, P.; López, R.C.; Vila-Jato, J.L.; Alonso, M.J. Novel hydrophilic chitosan–polyethyleneoxide nanoparticles as protein carriers. J. Appl. Polym. Sci., 1997, 63, 125-132.
[http://dx.doi.org/10.1002/(SICI)1097-4628(19970103)63:1<125:AID-APP13>3.0.CO;2-4]
[11]
Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm., 2008, 69(1), 1-9.
[http://dx.doi.org/10.1016/j.ejpb.2007.08.001] [PMID: 17826969]
[12]
Janardhanan, S.K.; Ramasamy, I.; Nair, B.U. Synthesis of iron oxide nanoparticles usingchitosan and starch templates. Trans. Met. Chem., (Weinh.), 2008, 33(1), 127-131.
[http://dx.doi.org/10.1007/s11243-007-9033-z]
[13]
Box, G.E.P.; Hunter, J.S.; Hunter, W.G. Statistics for experimenters: Design, innovation, and discovery, 2nd ed; John Wiley & Sons, Inc.: Hoboken, New Jersey, 2005.
[14]
Myers, R.H.; Montgomery, D.C.; Anderson-Cook, C.M. Response Surface Methodologyin Process and Product Optimization Using De-signed Experiments, 3rd ed; JohnWiley & Sons, Inc.: Hoboken, New Jersey, 2009.
[15]
Zhao, H.; Gagnon, J.; Häfeli, U.O. Process and formulation variables in the preparation of injectable and biodegradable magnetic micro-spheres. Biomagn. Res. Technol., 2007, 5(1), 2.
[http://dx.doi.org/10.1186/1477-044X-5-2] [PMID: 17407608]
[16]
Ali, H.; Kalashnikova, I.; White, M.A.; Sherman, M.; Rytting, E. Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. Int. J. Pharm., 2013, 454(1), 149-157.
[http://dx.doi.org/10.1016/j.ijpharm.2013.07.010] [PMID: 23850397]
[17]
Feczkó, T.; Tóth, J.; Dósa, G.; Gyenis, J. Optimization of protein encapsulation in PLGA nanoparticles. Chem. Eng. Process., 2011, 50(8), 757-765.
[http://dx.doi.org/10.1016/j.cep.2011.06.008]
[18]
Pathak, K.; Das, A.; Shakya, A.; Saikia, R.; Sarma, H. Evaluation of anti-diabetic and anti-hyperlipidemic activity of isolated bioactive compounds of leaves of Annona reticulata Linn. Nat. Prod. J., 2020, •••, 10.
[19]
Gurunathan, S.; Kang, M.H.; Qasim, M.; Kim, J.H. Nanoparticle-mediated combination therapy: Two-in-one approach for cancer. Int. J. Mol. Sci., 2018, 19(10), 3264.
[http://dx.doi.org/10.3390/ijms19103264] [PMID: 30347840]
[20]
Danhier, F.; Ansorena, E.; Silva, J.M.; Coco, R.; Le Breton, A.; Préat, V. PLGA-based nanoparticles: An overview of biomedical applica-tions. J. Control. Release, 2012, 161(2), 505-522.
[http://dx.doi.org/10.1016/j.jconrel.2012.01.043] [PMID: 22353619]
[21]
Tefas, L.R. Tomuţă, I.; Achim, M.; Vlase, L. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Med., 2015, 88(2), 214-223.
[PMID: 26528074]
[22]
de Cristo Soares Alves, A.; Mainardes, R.M.; Khalil, N.M. Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxi-dant activity. Mater. Sci. Eng. C, 2016, 60, 126-134.
[http://dx.doi.org/10.1016/j.msec.2015.11.014] [PMID: 26706515]
[23]
Salem, H.F.; Kharshoum, R.M.; Sayed, O.M.; Abdel Hakim, L.F. Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design. Drug Dev. Ind. Pharm., 2018, 44(11), 1871-1884.
[http://dx.doi.org/10.1080/03639045.2018.1504963] [PMID: 30044654]
[24]
Li, H.; Zhao, X.; Ma, Y.; Zhai, G.; Li, L.; Lou, H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release, 2009, 133(3), 238-244.
[http://dx.doi.org/10.1016/j.jconrel.2008.10.002] [PMID: 18951932]
[25]
Lauro, M.R.; Torre, M.L.; Maggi, L.; De Simone, F.; Conte, U.; Aquino, R.P. Fast- and slow-release tablets for oral administration of fla-vonoids: Rutin and quercetin. Drug Dev. Ind. Pharm., 2002, 28(4), 371-379.
[http://dx.doi.org/10.1081/DDC-120002998] [PMID: 12056530]
[26]
Derakhshandeh, K.; Soheili, M.; Dadashzadeh, S.; Saghiri, R. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients. Int. J. Nanomedicine, 2010, 5, 463-471.
[http://dx.doi.org/10.2147/IJN.S11586] [PMID: 20957168]
[27]
Honary, S.; Zahir, F. Effect of zeta potential on the properties of nano-drug delivery systems - a review (Part 2). Trop. J. Pharm. Res., 2013, 12, 265-273.
[28]
Prabhat, R.; Mishra, L.; Al Shaal, B.; Müller, R.H.; Keck, C.M. Production and characterization of hesperetin nanosuspensions for dermal delivery. Int. J. Pharm., 2009, 371, 182-189.
[http://dx.doi.org/10.1016/j.ijpharm.2008.12.030] [PMID: 19162147]
[29]
Abul Kalam, M.; Khan, A.A.; Khan, S.; Almalik, A.; Alshamsan, A. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsu-lation, and release using Box-Behnken experimental design. Int. J. Biol. Macromol., 2016, 87, 329-340.
[http://dx.doi.org/10.1016/j.ijbiomac.2016.02.033] [PMID: 26893052]
[30]
Xu, D.; Aihemaiti, Z.; Cao, Y.; Teng, C.; Li, X. Physicochemical stability, microrheological properties and microstructure of lutein emul-sions stabilized by multilayer membranes consisting of whey protein isolate, flaxseed gum and chitosan. Food Chem., 2016, 202, 156-164.
[http://dx.doi.org/10.1016/j.foodchem.2016.01.052] [PMID: 26920280]

Rights & Permissions Print Cite
Article Metrics
16
1
© 2024 Bentham Science Publishers | Privacy Policy